Puget Sound Cancer Center is a clinical research site located in Seattle, Washington, United States 98133.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Puget Sound Cancer Center has participated in 6 clinical trials.
Therapeutic areas: Small Cell Lung Cancer, Myelodysplastic Syndromes, Breast Cancer.
Sponsors: Celgene, Syndax Pharmaceuticals, Novartis Pharmaceuticals.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Puget Sound Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Puget Sound Cancer Center has 6 clinical trials on record. Their work covers Small Cell Lung Cancer, Myelodysplastic Syndromes, Breast Cancer.
Yes — Puget Sound Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.